NREP
NEW REPRESENTATIVE AT IB RECEIVED
02/26/2026
Back to search
Official data from USPTO
HISTOGUARD
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
HISTOGUARD
ST13
US500000079270198Class
42, 44
Filing
79270198
Registration
6150038
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
31
Latest update
02/27/2026
Classification
Registered
Trademark type
Word
Nice classes
42, 44
Filing date
07/29/2019
Registration date
09/15/2020
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/15/2020
Last transaction
02/27/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
32
Owner location
BE
Examiner
CIANCI, RYAN MICHAEL
Law office
M70
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Histogenex, naamloze vennootschap
Representatives
Matthew P. Hintz, Esq. Lowenstein Sandler LLP
Technical classification
Nice Classes
Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Scientific and technological servicesresearchconsultancydevelopment and designclinical research in the field of canceroncologyneurologicalinflammatory diseasescancerous diseasesimmunotherapyhistopathologydigital pathologynext generation immunohistochemistrydna/mrnafluorescence and silver in-situ hybridizationmolecular pathology and all analytical methods covering morphological evaluation of specimens; medical laboratory services; clinical tests and clinical researchconducting clinical trial services for others and providing advisory services related to the conduction of clinical trials; scientific laboratory services; analytical scientific laboratory services; scientific research for medical purposes in the area of cancerous diseases; providing information in the field of conducting clinical trials for others in the nature of scientific reports and reports related to scientific research and clinical tests; scientific and medical research; providing medical and scientific research information in the field of clinical trials; genetic testing for scientific research purposes; design and development of computer hardware and software
Class 44
Medical services; medical analysis services for the diagnosis of canceroncologicalneurological and inflammatory diseases; medical testing for diagnosis and treatment purposes; advisory services relating to physical health care; medical analysis services for the diagnosis of cancer and other diseases; RNA and DNA screening for cancer diagnosis and prognosis; pathology servicesmedical screening for cancer diagnosis and prognosis
Publications
History of USPTO decisions and trademark events.
31 publications found
NREP
NEW REPRESENTATIVE AT IB RECEIVED
11/07/2025
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
09/15/2025
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
01/23/2021
FICS
FINAL DISPOSITION NOTICE SENT TO IB
12/31/2020
FIMP
FINAL DISPOSITION PROCESSED
12/30/2020
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
12/15/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
09/15/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/30/2020
PUBO
PUBLISHED FOR OPPOSITION
06/30/2020
GPNX
NOTIFICATION PROCESSED BY IB
06/27/2020
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
06/10/2020
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
06/10/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/10/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/28/2020
XAEC
EXAMINER'S AMENDMENT ENTERED
05/28/2020
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
05/28/2020
GNEA
EXAMINERS AMENDMENT E-MAILED
05/28/2020
CNEA
EXAMINERS AMENDMENT -WRITTEN
05/28/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/21/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/21/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/21/2020
RFNT
REFUSAL PROCESSED BY IB
12/20/2019
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
11/23/2019
RFRR
REFUSAL PROCESSED BY MPU
11/22/2019
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
11/02/2019
CNRT
NON-FINAL ACTION WRITTEN
11/01/2019
MAFR
APPLICATION FILING RECEIPT MAILED
11/01/2019
DOCK
ASSIGNED TO EXAMINER
10/28/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/28/2019
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
10/24/2019
Continuous trademark protection
Get notified about every new filing that threatens HISTOGUARD or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.